PRODUCT DESCRIPTION
This blend approaches growth-hormone research through two complementary pathways. CJC-1295 No DAC supports the natural GHRH signal, while ipamorelin activates the ghrelin receptor to encourage growth hormone release. Researchers are interested in whether using both signals together may produce a stronger or more balanced pulse and support recovery, sleep, metabolism, and body-composition research.
Potential research benefits
- Two complementary GH signals: The blend approaches growth hormone release from two directions, giving researchers a compelling way to study a fuller and potentially stronger natural-style response.
- Improved recovery and tissue repair: Increased GH and IGF-1 activity may support the rebuilding processes involved in muscle recovery, connective-tissue maintenance, and adaptation to training.
- Deeper, more restorative sleep: Researchers are interested in how combined GH stimulation may relate to sleep quality, nighttime recovery, and morning readiness.
- Support for lean mass and fat metabolism: The blend is studied for potential changes in body composition, including preservation of lean tissue and improved use of stored fat.
- A more balanced research profile: Ipamorelin's selectivity combined with the shorter action of CJC-1295 No DAC makes the pairing appealing for studying controlled GH pulses without prolonged stimulation.
Why researchers are interested
Both pathways are supported by established hormone research, giving the combination a strong scientific rationale. The blend is especially popular for investigating combined GH and IGF-1 responses, although dedicated controlled studies are still needed to confirm whether the two compounds provide meaningful synergy.